The 20 Best Malignant Mixed Mullerian Tumor Doctors Near Me in New York, US

. Dr. Pelkofski is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Bladder Reconstruction. Dr. Pelkofski is board certified in American Board Of Obstetrics And Gynecology (Obstetrics & Gynecology, Gynecologic Oncology).

. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

. Dr. Allerton is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Allerton is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine, Medical Oncology, American Board Of Internal Medicine, Hospice And Palliative Medicine, and American Board Of Internal Medicine, Internal Medicine.

. Dr. Parylo is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Leukocytosis, and Small Cell Lung Cancer (SCLC). Dr. Parylo is board certified in American Board Of Internal Medicine.

. Dr. Chanana is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Endometrial Polyps, Cervical Dysplasia, Vaginal Bleeding Between Periods, and Female Genital Sores.

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, and Malignant Mixed Mullerian Tumor. Dr. John is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Patrick F. Timmins III, MD, FACOG, FACS, is an attending physician at Montefiore Einstein and Vice Chair, Legislative Affairs at our Albert Einstein College of Medicine. Dr. Timmins addresses the individual needs and demands of patients in a warm and caring environment, providing a full range of gynecologic oncology services, including advanced gynecologic surgery, robotic surgery, chemotherapy treatment and palliative care. Dr. Timmins is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Hernia Surgery.

Jill Whyte is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Whyte is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Adult Soft Tissue Sarcoma, Oophorectomy, and Salpingo-Oophorectomy. Dr. Whyte is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

"Andrew Menzin, MD, is an OB/GYN and oncology specialist at Northwell Health Physician Partners Gynecologic Oncology at New Hyde Park. He is also the chief of gynecologic oncology for Northwell facilities across central Long Island and Queens, and the vice chairman of academic affairs for the OB/GYN service line. Dr. Menzin has nearly three decades of experience in gynecologic oncology and academic medicine.""I come from a family of doctors,"" he says. ""Education, medicine and service to others was just part of how I grew up.""Dr. Menzin treats the full spectrum of gynecologic issues, from benign conditions to all malignancies of the female reproductive system. His extensive surgical expertise includes cancer surgery, robotic surgery and complex gynecologic surgery.He joined Northwell Health in 1995, after completing a fellowship in gynecologic oncology and a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania.""At Northwell, we're here to meet every patient's needs and deliver truly collaborative care,"" says Dr. Menzin, who works closely with specialists including pathologists, radiologists, medical oncologists, radiation oncologists, general surgeons, colorectal surgeons and urologists. He carefully explains this multifaceted care to each patient-even drawing his unique diagrams for extra clarity.Dr. Menzin is a professor of obstetrics and gynecology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is a member of the Society of Gynecologic Oncology, as well as a fellow of the American College of Surgeons and the American College of Obstetricians and Gynecologists. He's been named numerous times on the Castle Connolly Top Doctors list, and he's an avid supporter of the National Ovarian Cancer Coalition, which supports ovarian cancer survivors and funds research to find a cure.""I have had great mentors who've inspired me along the way,"" says Dr. Menzin. ""It's all about delivering care that's patient-centered. Looking after them the way I'd want to be cared for.""". Dr. Menzin is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hernia Surgery, and Hysterectomy. Dr. Menzin is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Lisa Santos is an Oncologist practicing medicine in Huntington, New York. Dr. Santos is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Angiomyoma, Hernia Surgery, and Hysterectomy. Dr. Santos is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Dr Gretz specializes in gynecologic oncology and gynecologic minimally invasive and robotic surgery.Dr Gretz completed fellowship training in gynecologic oncology at the University of Michigan. Dr Gretz has been performing robotic surgery since 2005, and has performed thousands of laparoscopic procedures. Dr. Gretz is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Hernia Surgery.

Timothy Mcelrath is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Albany, New York. He has been practicing medicine for over 33 years. Dr. Mcelrath is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Bladder Reconstruction, and Ureteroscopy. Dr. Mcelrath is board certified in American Board Of Obstetrics & Gynecology Subspecialty, Gynecologic Oncology , American Board Of Obstetrics And Gynecology Subspecialty, Gynecologic Oncology , and American Board Of Obstetrics And Gynecology. Dr. Mcelrath is currently accepting new patients.

Mario Leitao is a Gynecologic Oncologist and an Oncologist practicing medicine in New York, New York. Dr. Leitao is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vulvar Cancer, Vaginal Cancer, Hysterectomy, and Lymphadenectomy. Dr. Leitao is currently accepting new patients.

Joyce Barlin is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Albany, New York. She has been practicing medicine for over 20 years. Dr. Barlin is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, and Bladder Reconstruction. Dr. Barlin is board certified in American Board Of Obstetrics And Gynecology Subspecialty, Gynecologic Oncology and American Board Of Obstetrics & Gynecology, Obstetrics And Gynecology. Dr. Barlin is currently accepting new patients.

Seth Cohen is an Oncologist practicing medicine in New York, New York. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Pseudomyxoma Peritonei, Ovarian Cancer, Glossectomy, and Endoscopy. Dr. Cohen is currently accepting new patients.

Carol Aghajanian is an Oncologist practicing medicine in New York, New York. Dr. Aghajanian is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Ovarian Carcinosarcoma, and Salpingo-Oophorectomy. Dr. Aghajanian is currently accepting new patients.

June Y. Hou, MD is an Associate Professor of Obstetrics & Gynecology at the Columbia University Medical Center. Dr. Hou received her undergraduate degree at Yale College with Honors, and completed medical school at Georgetown University School of Medicine. After completing her residency training at Yale New Haven Hospital, she pursued a gynecologic oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center. She is board certified in Obstetrics and Gynecology and Gynecologic Oncology, and also has a Master Degree of Business Administration from Columbia Business School.She joins the faculty at Columbia University Medical Center with a research interest in promoting equity and diversity in clinical trials, and quality of life measures in clinical trial participants. Her clinical interest encompasses expanding awareness of heredity gynecological cancers and access to care, along with clinical outreach. A past recipient of a career development grant focusing on molecular pathogenesis of ovarian cancer and rare uterine cancers, Dr. Hou has given numerous nationally-recognized presentations based on her work, and has led numerous clinical trials. Clinically, Dr. Hou is certified in minimally invasive surgery, including robotic-assisted surgery. Her expertise includes novel and traditional chemotherapeutics and complex pelvic surgeries. Her goal is to provide compassionate and individualized care to all women with pre-malignant or gynecological cancers. Dr. Hou is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Sertoli-Leydig Cell Tumor, Hysterectomy, and Oophorectomy. Dr. Hou is board certified in Obstetrics And Gynecology and Hospice And Palliative Medicine. Dr. Hou is currently accepting new patients.

Kevin Holcomb is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Holcomb is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Oophorectomy, and Salpingo-Oophorectomy. Dr. Holcomb is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Joan Tymon is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Tymon is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tymon is board certified in American Board Of Obstetrics & Gynecology.

"Eli Serur, MD, is the chair of obstetrics and gynecology at Staten Island University Hospital. He is a double board-certified surgeon who specializes in gynecologic oncology.Dr. Serur's passion for oncology started as a medical student at NYU Grossman School of Medicine. During a pathology internship, he appreciated the gratification that comes from detecting cancers early and offering care that allows patients to live better and longer. ""The ability to treat patients over a long time frame was very appealing. I liked the thought of staying connected with them and developing meaningful relationships that improved their quality of life,"" he says.After completing his residency at Kings County Hospital Center and fellowship at SUNY Downstate Health Sciences University, Dr. Serur spent 27 years as director of gynecologic oncology at The Brooklyn Hospital Center, followed by 22 years as director of gynecologic oncology and minimally invasive surgery at Richmond University Medical Center. He joined Northwell Health in 2019, bringing considerable expertise in complex surgical techniques with a focus on minimally invasive procedures, such as laparoscopic surgeries for ovarian cysts and masses, uterine fibroids, ovarian and cervical cancers, and endometriosis.""With these surgeries, patients can return home much faster, sometimes even the same day,"" he says. ""That speeds recovery, enables them to return to normal activities and leads to better outcomes.""Dr. Serur was one of the first physicians in the country to advocate for abandoning a technique known as morcellation, in which uterine fibroids are removed by dividing tissue into numerous fragments, increasing the risk of undetected cancerous tissue spreading within the uterus. He was also one of the first to develop an alternate, innovative technique that could remove fibroids far more safely. In 2014, the Food and Drug Administration issued a warning against the procedure, in part thanks to Dr. Serur's efforts.As part of a team of experts who work together to create personalized treatment plans-including medical and radiation oncologists, nutritionists and other specialists-Dr. Serur is dedicated to what he sees as his most important skill: listening to patients. ""I feel that I'm empathetic, and that comes from making sure my patients have a voice in their care,"" he says. ""Communication and trust are everything when it comes to cancer treatment-that's what drives recovery.""". Dr. Serur is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Hysterectomy, and Hernia Surgery. Dr. Serur is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.